🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

SuperCAP Program to Improve Cognition and Daily Functioning in Post-COVID-19 Condition

RecruitingNAAges 18 Years - 65 YearsAllFundación FLS de Lucha Contra el Sida, las Enferm…
NCT07530757 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The goal of this study is to determine whether the SuperCAP intervention program is superior to control in reducing disability from baseline to the post-intervention assessment in people with Post-COVID-19 Condition. The main question it aims to answer is whether participants assigned to SuperCAP experience a greater reduction in disability, defined as an improvement of at least 5 points on the WHODAS 2.0 from baseline to the post-intervention visit, compared with participants in the control group. Participants assigned to the SuperCAP intervention will undergo a series of sessions that include psychoeducation, adaptive cognitive training exercises, fatigue self-management strategies, and multidisciplinary content.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Diagnosis of PCC, defined as the presence of three or more symptoms associated with COVID-19 infection for at least three months, not explained by other diseases. * Age 18 to 65 years. * Willingness to participate in an app-based intervention program aimed at improving daily Functioning in People Living with PCC. * Evidence of patient-reported cognitive difficulties emerging after COVID-19, operationalized as a WHODAS 2.0 Cognition Domain (D1) score \> 6 at baseline via RedCAP. * Digital proficiency defined as scoring ≥4 on MDPQ-16 item 2a (sending emails) and ≥3 on item 6a (using the device's app store) via RedCAP. * Self-reported ability to use a mobile application for approximately 15 minutes per day, 5 days per week, considering their current symptoms. * Possession of a personal smartphone compatible with the study mobile application (eSalut), with sufficient storage space and operating system version required for installation. Exclusion Criteria: * Inability to undergo neuropsychological tests or additional assessments. * Prior use of the SuperCAP program. * Current participation in a trial or program aimed at improving PCC symptoms. * Any condition that, in the investigator's opinion, could make participation unsafe, complicate interpretation of study results, interfere with achievement of study objectives, or otherwise affect the participant's ability to complete the study.
💊

What it tests

  • SuperCAP intervention program
  • Psychoeducational intervention
📍

Where

1 site
Fundació Lluita contra les Infeccions - Hospital Universitari Germans Trias i Pujol
Badalona, Spain
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy